Cargando…
Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis
The small interfering RNA (siRNA) is suggested to offer a novel means of treating atopic dermatitis (AD) because it allows the specific silencing of genes related to AD pathogenesis. In our previous study, we found that siRNA targeted against RelA, an important nuclear factor-kappa B (NF-κB) subdoma...
Autores principales: | Kanazawa, Takanori, Shizawa, Yuki, Takeuchi, Mayu, Tamano, Kuniko, Ibaraki, Hisako, Seta, Yasuo, Takashima, Yuuki, Okada, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588201/ https://www.ncbi.nlm.nih.gov/pubmed/26371030 http://dx.doi.org/10.3390/pharmaceutics7030294 |
Ejemplares similares
-
Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide
por: Ibaraki, Hisako, et al.
Publicado: (2016) -
Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
por: Kanazawa, Takanori, et al.
Publicado: (2019) -
Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478
por: Kanazawa, Takanori, et al.
Publicado: (2019) -
Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles
por: Ibaraki, Hisako, et al.
Publicado: (2020) -
In Vivo Fluorescence Imaging of Passive Inflammation Site Accumulation of Liposomes via Intravenous Administration Focused on Their Surface Charge and PEG Modification
por: Ibaraki, Hisako, et al.
Publicado: (2021)